Emera (EMA) Earnings Analysis
Emera (EMA) next reports earnings on 2026-08-07, consensus EPS 0.504 USD. Last quarter (2026-05-08) it beat with EPS 0.985 USD vs 0.866 USD est (+13.7%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 23.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EMA next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | 0.504 USD |
| Revenue estimate | 1.34B |
EMA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | 0.985 USD | 0.866 USD | +13.7% | Beat |
| 2026-02-23 | 0.4005 USD | 0.4167 USD | -3.9% | Miss |
| 2025-11-07 | 0.64 USD | 0.4394 USD | +45.7% | Beat |
| 2025-08-07 | 0.57 USD | 0.4653 USD | +22.5% | Beat |
| 2024-12-31 | 0.585 USD | 0.531 USD | +10.2% | Beat |
| 2024-09-30 | 0.07584 USD | 0.578 USD | -86.9% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
EMA valuation and analyst view
| Trailing P/E | 23.33 |
|---|---|
| Trailing EPS | 3.528 USD |
| Price / book | 1.64 |
| Dividend yield | 3.82% |
| Market cap | 16.69B |
| Analyst consensus | Hold (0 buy / 2 hold / 0 sell) |
| Avg price target | 52.5 USD |
Related research pages
Frequently asked questions
When is Emera (EMA)'s next earnings date?
Emera is next scheduled to report on 2026-08-07, with a consensus EPS estimate of 0.504 USD and revenue estimate of 1.34B.
Did EMA beat earnings last quarter?
In its 2026-05-08 report, EMA posted EPS of 0.985 USD versus a 0.866 USD estimate — a beat of 13.7%.
What is EMA's earnings track record?
Over the last 6 reported quarters with consensus data, EMA beat estimates 4 times (67%).
What is EMA's current P/E ratio and EPS?
EMA trades at a trailing P/E of 23.33 on trailing EPS of 3.527860204418068 USD.
What do analysts rate EMA?
Analyst consensus is "Hold" across 2 ratings (0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 52.5 USD.